Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ilika Plc | LSE:IKA | London | Ordinary Share | GB00B608Z994 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.25 | 1.37% | 18.50 | 92,816 | 08:04:23 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 18.00 | 19.00 | 18.50 | 18.00 | 18.25 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 2.09M | -4.81M | -0.0288 | -6.42 | 30.53M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 08:15:53 | O | 26,461 | 18.88 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/11/2024 | 07:00 | UK RNS | Ilika plc Goliath D6 milestone reached |
| 15/11/2024 | 11:49 | ALNC |  Ilika eyes interim revenue fall due to timing of projects |
| 15/11/2024 | 07:00 | UK RNS | Ilika plc Trading Update & Notice of Half-Year Results |
| 10/10/2024 | 12:49 | UK RNS | Ilika plc Holding(s) in Company |
| 03/10/2024 | 06:00 | UK RNS | Ilika plc Further Goliath Technical Milestone Achieved |
| 24/9/2024 | 15:30 | UK RNS | Ilika plc Result of AGM & Award of Executive Share Options |
| 05/9/2024 | 06:00 | UK RNS | Ilika plc Goliath safety test results |
| 29/8/2024 | 06:00 | UK RNS | Ilika plc Posting of Annual Report and Notice of AGM |
| 11/7/2024 | 17:13 | ALNC | EARNINGS AND TRADING: MJ Gleeson optimistic; Hornby annual profit down |
| 11/7/2024 | 06:00 | UK RNS | Ilika plc Final Results |
Ilika (IKA) Share Charts1 Year Ilika Chart |
|
1 Month Ilika Chart |
Intraday Ilika Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 20/11/2024 | 20:55 | ILIKA - Multiple Material Opportunities! | 5,374 |
| 05/4/2024 | 11:28 | huge interest in pipeline.... | 3 |
| 12/7/2023 | 19:38 | Ilika - First thread | 636 |
| 30/3/2022 | 19:47 | Ilika (IKA) One to Watch on Monday | 28 |
| 04/2/2020 | 14:16 | Ilika | 1 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 08:15:54 | 18.88 | 26,461 | 4,995.84 | O |
| 08:04:04 | 18.00 | 555 | 99.90 | O |
| 08:03:33 | 18.50 | 5,000 | 925.00 | O |
| 08:03:30 | 18.50 | 10,000 | 1,850.00 | O |
| 08:02:52 | 18.50 | 12,500 | 2,312.50 | O |
| Top Posts |
|---|
Posted at 21/11/2024 08:20 by Ilika Daily Update Ilika Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker IKA. The last closing price for Ilika was 18.25p.Ilika currently has 167,303,091 shares in issue. The market capitalisation of Ilika is £30,951,072. Ilika has a price to earnings ratio (PE ratio) of -6.42. This morning IKA shares opened at 18.25p |
Posted at 20/11/2024 08:15 by robertspc1 Sense a bit more urgency in todays RNS. The share price collapse might finally get the message through to management... get on with it quickly |
Posted at 12/11/2024 13:17 by phil2003 Don’t panic Tanja.. They’re gonna call an urgent meeting asap next month, certainly pre Christmas.. to agree the framework for an urgent conversation followed by an agreement to move towards a robust deep dive into the recent share price collapse over the last 2 years.As a shareholder, you can expect full transparency, delivered at pace, regarding the new plan to discuss, minute and implement a rapid plan to keep the existing management in role & rehash some old news by Q2 2025.. 😂😂 #grantfunded #academics I’ve just glanced at my recent soundhound & block gains.. dynamic companies both.. unlike this soporific bunch 💤 |
Posted at 25/10/2024 09:35 by tp5588 Been invested since 2016. Every interview/presentati |
Posted at 24/10/2024 21:02 by phil2003 ‘At Pace’ Purdey now has to deal with institutional bail outs, horrific price action (chart) with a 2 year down trend, lower lows and all Ilika supporters now well underwater and sitting on significant £ losses, viewing any upticks merely as an opportunity to get out.. we are now looking at a house of cards where institutional investors will (have to) cut their losses at predetermined levels (unlike some pi’s.. naming no names)Not to worry.. ‘at pace’ Purdey has, and I quote, said the EV battery market will be worth £9B by 2030 and Ilika plan to “ensure their Goliath tech is available for that eventuality” Yawn |
Posted at 05/9/2024 13:20 by robertspc1 As European auto OEMs continue to struggle and gigafactories get cancelled, the battery market is consolidating rapidly. Ninety per cent of the battery market is held by just nine Asian companies. Sooner or later IKA is going to have to partner with one of them. Agratas will be good start but a Korean, Chinese or Japanese partner essential |
Posted at 02/7/2024 07:11 by kenjen1 Once upon a time today’s news would be greeted with significant buying and share price rise. However I feel people don’t believe this story anymore. MultipleDelays, lack of belief from investors and little appetite for ilika at the moment. For example, what on earth has happened to Stereax? Anyone? Good to see some P1 samples being sent, let’saee if they meet customer requirements |
Posted at 23/4/2024 19:54 by robertspc1 Presentation must have been fabulous given the share price reaction ... or maybe not |
Posted at 28/3/2024 13:38 by malnu What participants on this site clearly don’t understand is the commercial tactics around its technology. In the trade it’s called the secret sauce. IKA know they have the best-in-class SSB technology.So, IKA must first allow competitors to go sufficiently down the wrong road until they reach the point of no return. QS, and others, have now gone sufficiently down that road of no return. Which is why IKA can now elaborate a little more than before. It’s been slow and frustrating, but the tactics are absolutely correct. |
Posted at 22/3/2024 15:48 by robertspc1 I understand your view. However occasionally the market totally misprices small companies which few analysts follow and are thinly traded. Most recent example for me was Northbridge which got totally trashed following some poorly timed acquisitions. But there was a very good underlying business which inevitably was on corporate radars. I kept building a decent stake and sure enough a takeover came along. Different scenario here but eventually I think there will be corporate buyers or partners for both Stereax and Goliath. The share price doesn't reflect that in my opinion |
Posted at 20/2/2023 04:29 by malnu hxxps://www.ii.co.ukThe Stereax M300 miniature battery should be launched by the summer after some delays last year. A manufacturing licence deal with Cirtec Medical will enable a significant boost in production for Stereax. Machinery will be transferred to Cirtec Medical’s factory in Massachusetts as part of the tech transfer deal. There are initial orders from 18 medical companies and there is plenty of scope for increasing production as required. This is not an exclusive deal and similar deals can be made around the world. Ilika continues to own the intellectual property and it can put more resources into developing the customer base, as well as further investment in the technology. The larger Goliath battery is on the way to reaching parity with equivalent lithium-ion batteries. It is designed to be cost-effective and recyclable. Ilika has been awarded a UK government grant of £2.8 million for taking a leading role on a 24-month Faraday Battery Challenge in collaboration with BMW and Williams. This will further the development of the Goliath battery for automotive use. Net cash was £17.8 million at the end of October 2022. The cash should last well into 2024, but there will be a requirement for more cash as Ilika approaches breakeven. By that time there sh ould be positive news concerning demand for Stereax batteries from medical device companies. The potential for Stereax more than underpins the share price, leaving no value attributed to Goliath. Take a long-term view of this investment. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
